Urine drug testing for medication-assisted treatment (MAT)

Treatment professionals agree that monitoring drug use during MAT can be a powerful incentive for abstinence, and it can also help identify OUD relapse.

Clinical drug testing is an important tool in managing patients who are receiving MAT. During this webinar, our toxicology experts review Labcorp’s MAT portfolio and provide answers to questions that can help you leverage our differentiated services to their full potential.

This webinar includes:

• Overview of MAT and the importance of clinical drug testing
• Drug testing trends within the MAT population
• The clinical value of advanced specimen validity testing
• Review of specialized MAT testing options and the unique components designed to help you manage patients receiving treatment with buprenorphine/Suboxone®
• Q&A with the presenters

Presenters

Hemamalini Ketha, PhD, NRCC, SC (ASCP), FAACC
Discipline Director, Clinical Toxicology

Karla J. Walker, PharmD, DABCC, FAACC
Discipline Director, Clinical Toxicology